First human test for new HIV drug candidate
NCT ID NCT05631704
Summary
This was the first study in humans for a new drug called VH4524184, which is being developed for HIV. The main goal was to check if the drug is safe and to see how the body processes it. The study involved 84 healthy volunteers who received either the drug or a placebo, and researchers closely monitored for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Baltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.